Table 2.
COVID-19 vaccinated | n = 441 |
---|---|
Vaccine | |
Pfizer, n (%) | 380 (86.2) |
Moderna, n (%) | 14 (3.2) |
Astra-Zeneca, n (%) | 44 (10.0) |
Johnson & Johnson, n (%) | 3 (0.7) |
Adverse effects, rates | 148/441 |
1st dose, n (%) | 107 (24.3) |
2nd dose, n (%) | 108 (24.5) |
Both doses, n (%) | 67 (15.2) |
Disease flare, rates | |
1st dose, n (%) | 1 (0.23) |
2nd dose, n (%) | 8 (1.81) |
Type of vaccine received, rates of adverse effects and disease flare